Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

被引:43
|
作者
Luc, G. [1 ,2 ,3 ]
Empana, J-P [4 ,5 ]
Morange, P. [6 ]
Juhan-Vague, I. [6 ]
Arveiler, D. [7 ]
Ferrieres, J. [8 ]
Amouyel, P. [9 ]
Evans, A. [10 ]
Kee, F. [10 ]
Bingham, A. [4 ,5 ]
Machez, E. [1 ,2 ,3 ]
Ducimetiere, P. [4 ,5 ]
机构
[1] Univ Lille 2, INSERM U545, Fac Med, F-59037 Lille, France
[2] Univ Lille Nord France, Lille, France
[3] UDSL, Lille, France
[4] Paris Cardiovasc Res Ctr PAARC, INSERM U970, Paris, France
[5] Univ Paris 05, Paris, France
[6] La Timone Hosp, INSERM U626, Hematol Lab, Marseille, France
[7] Fac Med Strasbourg, Dept Epidemiol & Publ Hlth, Strasbourg, France
[8] INSERM U558, Dept Epidemiol, Toulouse, France
[9] Inst Pasteur, INSERM U744, F-59019 Lille, France
[10] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland
关键词
myocardial infarction; coronary heart disease; adipokine; CRP; epidemiology; MOLECULAR-WEIGHT ADIPONECTIN; TYPE-2; DIABETES-MELLITUS; PLASMINOGEN-ACTIVATOR INHIBITOR; ACUTE MYOCARDIAL-INFARCTION; PLASMA RESISTIN LEVELS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ARTERY-DISEASE; FOLLOW-UP; CARDIOVASCULAR-DISEASE;
D O I
10.1038/ijo.2009.204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adipokines play an important role in glucose, lipid and lipoprotein metabolisms, as well as in coagulation and inflammatory processes. So far, studies have evaluated the association of individual adipokines with future coronary heart disease (CHD) event and provided mixed results. Objectives: We sought to investigate the association of a set of adipocytokines, including total adiponectin, adipsin, resistin, leptin and plasminogen activator inihibitor-1 (PAI-1), with future CHD events in apparently healthy men. Methods: We built a nested case-control study within the PRIME Study, a multicenter prospective cohort of 9779 healthy European middle-aged men. Total adiponectin, adipsin, resistin, leptin and PAI-1 were measured in the baseline plasma sample of 617 men who developed a first CHD event (coronary death, myocardial infarction, stable or unstable angina) during 10 years of follow-up and in 1215 study-matched controls, by multiplex assays using commercial kits. HRs for CHD were estimated by conditional logistic regression analysis. Results: Median concentrations of total adiponectin, adipsin and resistin were similar in cases and in controls, whereas those of leptin and PAI-1 were higher in cases than in controls, 6.30 vs 5.40 ng ml(-1), and 10.09 vs 8.48 IU ml(-1), respectively. The risk of future CHD event increased with increasing quintiles of baseline leptin and PAI-1 concentrations only in unadjusted analysis (P-value for trend <0.003 and <0.0001, respectively). However, these associations were no longer significant after adjustment for usual CHD risk factors including hypertension, diabetes, smoking, total cholesterol, triglycerides and HDL cholesterol. Conversely, baseline CRP and IL-6 levels remained associated with CHD risk in multivariate analysis. Conclusions: In apparently healthy men, circulating total adiponectin, adipsin, resistin, leptin and PAI-1 were not independent predictors of future CHD event. International Journal of Obesity (2010) 34, 118-126; doi:10.1038/ijo.2009.204; published online 13 October 2009
引用
收藏
页码:118 / 126
页数:9
相关论文
共 50 条
  • [1] Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study
    G Luc
    J-P Empana
    P Morange
    I Juhan-Vague
    D Arveiler
    J Ferrieres
    P Amouyel
    A Evans
    F Kee
    A Bingham
    E Machez
    P Ducimetiere
    [J]. International Journal of Obesity, 2010, 34 : 118 - 126
  • [2] Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study
    Troughton, J. A.
    Woodside, J. V.
    Yarnell, J. W. G.
    Arveiler, D.
    Amouyel, P.
    Ferrieres, J.
    Ducimetiere, P.
    Patterson, C. C.
    Luc, G.
    [J]. ATHEROSCLEROSIS, 2008, 197 (02) : 556 - 563
  • [4] Depressive Symptoms, a Time-Dependent Risk Factor for Coronary Heart Disease and Stroke in Middle-Aged Men The PRIME Study
    Majed, Bilal
    Arveiler, Dominique
    Bingham, Annie
    Ferrieres, Jean
    Ruidavets, Jean-Bernard
    Montaye, Michele
    Appleton, Katherine
    Haas, Bernadette
    Kee, Frank
    Amouyel, Philippe
    Ducimetiere, Pierre
    Empana, Jean-Philippe
    [J]. STROKE, 2012, 43 (07) : 1761 - 1767
  • [5] Adipokines and the risk of type 2 diabetes in healthy middle-aged men: the PRIME study
    Neville, C. E.
    McKinley, M. C.
    Kee, F.
    Linden, G. J.
    Evans, A.
    Patterson, C. C.
    Yarnell, J.
    Young, I. S.
    Woodside, J. V.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2011, 70 (OCE3) : E70 - E70
  • [6] Low plasma retinol predicts coronary events in healthy middle-aged men: The PRIME Study
    Gey, K. Fred
    Ducimetiere, Pierre
    Evans, Alun
    Amouyel, Philippe
    Arveiler, Dominique
    Ferrieres, Jean
    Luc, Gerald
    Kee, Frank
    Bingham, Annie
    Yarnell, John
    Cambien, Francois
    [J]. ATHEROSCLEROSIS, 2010, 208 (01) : 270 - 274
  • [7] Risk of coronary heart disease and activation of factor XII in middle-aged men
    Miller, GJ
    Esnouf, MP
    Burgess, AI
    Cooper, JA
    Mitchell, JP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 2103 - 2106
  • [8] RISK-FACTORS FOR CORONARY HEART-DISEASE IN MIDDLE-AGED MEN
    LOGAN, RL
    RIEMERSMA, R
    THOMSON, M
    HARGREAVES, A
    OLIVER, MF
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1990, 103 (899) : 490 - 490
  • [9] Family support and risk factors of coronary heart disease in middle-aged men
    Julkunen, Juhani
    Igna, Cornel
    Vanhanen, Hannu
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (3-4) : 203 - 203
  • [10] Body mass index, hypertension and 5-year coronary heart disease incidence in middle aged men:: the PRIME study
    Mahamat, A
    Richard, F
    Arveiler, D
    Bongard, V
    Yarnell, J
    Ducimetière, P
    Ruidavets, JB
    Haas, B
    Bingham, A
    Evans, A
    Amouyel, P
    Dallongeville, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (03) : 519 - 524